This compound is a pharmaceutical intermediate used in the production of kinase inhibitors, including baricitinib. It acts as a JAK1 and JAK2 inhibitor, relevant for research into immunomodulatory therapies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1187594-13-3
(4-(1-(3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate
pharmaceutical intermediate
2-Bromo-5-(4-methylbenzene-1-sulfonyl)-5H-pyrrolo[2,3-b]pyrazine
pharmaceutical intermediate
2,4-Dichloro-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine
pharmaceutical intermediate
Tert-Butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
pharmaceutical intermediate
1-(benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
pharmaceutical intermediate
4-(Dimethylamino)but-2-ynoic acid hydrochloride
pharmaceutical intermediate
6-Chloroquinoline-3-carboxylic acid
pharmaceutical intermediate
(2R)-2-(Aminomethyl)-1-pyrrolidinecarboxylic acid phenylmethyl ester
pharmaceutical intermediate
2-[1-ethylsulfonyl-3-[4-[7-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-d]pyrimidin-4-yl]pyrazol-1-yl]azetidin-3-yl]acetonitrile
WUWJJJDMZWZKQS-UHFFFAOYSA-N
CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CN(C4=NC=N3)COCC[Si](C)(C)C
—